These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33348088)

  • 1. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
    Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
    Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
    Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M;
    Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
    van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
    J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.
    van Kessel E; Snijders TJ; Baumfalk AE; Ruis C; van Baarsen KM; Broekman ML; van Zandvoort MJE; Robe PA
    J Neurooncol; 2020 Jan; 146(1):97-109. PubMed ID: 31802314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.
    Ediebah DE; Reijneveld JC; Taphoorn MJ; Coens C; Zikos E; Aaronson NK; Heimans JJ; Bottomley A; Klein M;
    Qual Life Res; 2017 Apr; 26(4):869-880. PubMed ID: 27744512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
    Caramanna I; Klein M; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Reijneveld JC;
    Qual Life Res; 2022 Nov; 31(11):3253-3266. PubMed ID: 35982202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "A prospective study of assessment of neurocognitive function in illiterate patients with gliomas treated with chemoradiation": Assessment of neurocognitive function in gliomas.
    Valiyaveettil D; G A; Malik M; Eaga P; Ahmed SF; Joseph D
    Cancer Treat Res Commun; 2021; 26():100288. PubMed ID: 33352469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour and surgery effects on cognitive functioning in high-grade glioma patients.
    Habets EJ; Kloet A; Walchenbach R; Vecht CJ; Klein M; Taphoorn MJ
    Acta Neurochir (Wien); 2014 Aug; 156(8):1451-9. PubMed ID: 24879620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
    Geens W; Vanlaer N; Nijland L; Van Laere S; Schwarze JK; Bruneau M; Neyns B; Rogiers A; Duerinck J
    J Neurooncol; 2024 May; 168(1):159-169. PubMed ID: 38502281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
    Wefel JS; Armstrong TS; Pugh SL; Gilbert MR; Wendland MM; Brachman DG; Roof KS; Brown PD; Crocker IR; Robins HI; Hunter G; Won M; Mehta MP
    Neuro Oncol; 2021 Jul; 23(7):1125-1138. PubMed ID: 33515019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies.
    Noll KR; Walbert T; Wefel JS
    Curr Opin Neurol; 2020 Dec; 33(6):716-722. PubMed ID: 33009006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between tumor location and neurocognitive functioning using tumor localization maps.
    Habets EJJ; Hendriks EJ; Taphoorn MJB; Douw L; Zwinderman AH; Vandertop WP; Barkhof F; De Witt Hamer PC; Klein M
    J Neurooncol; 2019 Sep; 144(3):573-582. PubMed ID: 31410731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.
    van der Meer PB; Habets EJJ; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Dirven L; Taphoorn MJB
    J Neurooncol; 2018 Sep; 139(2):359-368. PubMed ID: 29663172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment.
    van Kessel E; Emons MAC; Wajer IH; van Baarsen KM; Broekman ML; Robe PA; Snijders TJ; Van Zandvoort MJE
    Neurooncol Pract; 2019 Dec; 6(6):463-472. PubMed ID: 31832216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.
    Noll KR; Chen HS; Wefel JS; Kumar VA; Hou P; Ferguson SD; Rao G; Johnson JM; Schomer DF; Suki D; Prabhu SS; Liu HL
    Neurosurgery; 2021 Feb; 88(3):544-551. PubMed ID: 33080024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature.
    Weitzner MA; Meyers CA
    Psychooncology; 1997 Sep; 6(3):169-77. PubMed ID: 9313282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
    Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
    J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A research of preoperative neurocognitive functioning and contributing factors in patients with supratentorial gliomas.
    Wang L; Fang S; Peng Y
    Neurosci Lett; 2022 Apr; 775():136527. PubMed ID: 35167943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.
    Habets EJ; Dirven L; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Taphoorn MJ
    Neuro Oncol; 2016 Mar; 18(3):435-44. PubMed ID: 26385615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.